Intuitive Surgical, Inc. (NASDAQ:ISRG)‘s stock had its “buy” rating reissued by equities researchers at Canaccord Genuity in a report released on Friday. They currently have a $800.00 price objective on the stock. Canaccord Genuity’s price target suggests a potential upside of 4.26% from the stock’s current price.
A number of other equities analysts also recently commented on ISRG. Wedbush reaffirmed an “outperform” rating and issued a $800.00 price objective on shares of Intuitive Surgical in a report on Saturday, January 14th. Zacks Investment Research downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Wednesday, December 21st. Bank of America Corp set a $800.00 price objective on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Tuesday, February 14th. Finally, Evercore ISI downgraded shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $690.00 price objective for the company. in a report on Wednesday, January 4th. One research analyst has rated the stock with a sell rating, seven have given a hold rating and twelve have given a buy rating to the company’s stock. Intuitive Surgical presently has an average rating of “Buy” and an average price target of $736.10.
Intuitive Surgical (NASDAQ:ISRG) opened at 767.32 on Friday. The stock has a 50 day moving average of $732.60 and a 200-day moving average of $685.35. The stock has a market cap of $29.76 billion, a P/E ratio of 40.97 and a beta of 0.55. Intuitive Surgical has a one year low of $582.00 and a one year high of $769.12.
Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, January 24th. The company reported $6.09 EPS for the quarter, topping analysts’ consensus estimates of $5.99 by $0.10. The firm earned $757 million during the quarter, compared to the consensus estimate of $739.65 million. Intuitive Surgical had a net margin of 27.21% and a return on equity of 14.24%. The firm’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.89 earnings per share. Analysts anticipate that Intuitive Surgical will post $23.49 EPS for the current year.
ILLEGAL ACTIVITY WARNING: “Intuitive Surgical, Inc. (ISRG) Rating Reiterated by Canaccord Genuity” was originally published by Mideast Time and is the property of of Mideast Time. If you are reading this piece on another site, it was copied illegally and republished in violation of U.S. and international copyright laws. The correct version of this piece can be read at https://www.mideasttime.com/intuitive-surgical-inc-isrg-rating-reiterated-by-canaccord-genuity/1589954.html.
In other news, SVP Curet Myriam sold 222 shares of the business’s stock in a transaction on Friday, February 24th. The shares were sold at an average price of $729.80, for a total transaction of $162,015.60. Following the completion of the transaction, the senior vice president now owns 762 shares of the company’s stock, valued at $556,107.60. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Lonnie M. Smith sold 1,000 shares of the business’s stock in a transaction on Friday, January 27th. The shares were sold at an average price of $684.38, for a total transaction of $684,380.00. Following the transaction, the director now directly owns 234,971 shares of the company’s stock, valued at approximately $160,809,452.98. The disclosure for this sale can be found here. In the last three months, insiders have sold 34,118 shares of company stock valued at $25,064,571. Corporate insiders own 3.10% of the company’s stock.
Several institutional investors have recently made changes to their positions in the stock. Gerstein Fisher raised its position in Intuitive Surgical by 0.4% in the third quarter. Gerstein Fisher now owns 1,119 shares of the company’s stock worth $811,000 after buying an additional 4 shares during the last quarter. Atria Investments LLC raised its position in Intuitive Surgical by 1.3% in the third quarter. Atria Investments LLC now owns 462 shares of the company’s stock worth $335,000 after buying an additional 6 shares during the last quarter. Rothschild Asset Management Inc. raised its position in Intuitive Surgical by 1.1% in the third quarter. Rothschild Asset Management Inc. now owns 847 shares of the company’s stock worth $614,000 after buying an additional 9 shares during the last quarter. Sumitomo Mitsui Asset Management Company LTD raised its position in Intuitive Surgical by 0.3% in the third quarter. Sumitomo Mitsui Asset Management Company LTD now owns 2,893 shares of the company’s stock worth $2,096,000 after buying an additional 9 shares during the last quarter. Finally, Bradley Foster & Sargent Inc. CT raised its position in Intuitive Surgical by 0.7% in the third quarter. Bradley Foster & Sargent Inc. CT now owns 1,453 shares of the company’s stock worth $1,053,000 after buying an additional 10 shares during the last quarter. 91.16% of the stock is owned by institutional investors.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.